Related Experiment Video
Updated: Apr 15, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
10.1K
Biventricular pacemakers in patients with heart failure
1Karen Leslie Cooper is a clinical nurse specialist at Sutter Auburn Faith Hospital, Auburn, California. k4r3n@surewest.net.
Critical Care Nurse
|April 3, 2015
Summary
Biventricular pacemakers can help heart failure patients. These devices require more frequent and thorough patient assessments compared to traditional pacemakers.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Heart failure (HF) is a complex condition impacting millions globally.
- Traditional pacemakers manage heart rhythm but may not fully address HF symptoms.
- Biventricular pacing offers a potential therapeutic option for select HF patients.
Observation:
- This article reviews the clinical indications for biventricular pacemaker (BVP) implantation.
- It details the comprehensive assessment protocols necessary for patients receiving BVPs.
- Specialized evaluation is crucial for optimizing BVP therapy.
Findings:
- Biventricular pacemakers are indicated for specific heart failure patient profiles.
- Patient selection and ongoing monitoring are key components of successful BVP therapy.
- The assessment process for BVPs is more extensive than for conventional pacemakers.
Implications:
- Optimized BVP implantation and management can improve heart failure outcomes.
- Enhanced patient assessment ensures appropriate device utilization and efficacy.
- This approach highlights the evolving role of cardiac device therapy in heart failure management.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Heart Failure V: Medical Management
579
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
579
Heart Failure Drugs: β-Blockers
1.2K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy
803
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Heart Failure VI: Adjunct Therapies
610
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
610
Cardiomyopathy V: Interprofessional Care
711
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711

